Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Sichuan Province in China

Japanese Journal of Infectious Diseases

Volumn 61, Issue 4, 2008, Pages 264-268

  Guo, Jian Hua ^a   Xiang, Wen Liang ^a,b   Zhao, Qing Rong ^c   Luo, Tao ^c   Huang, Min ^a   Zhang, Jie ^a   Zhao, Jian ^a   Yang, Zhi Rong ^a   Sun, Qun ^a  

^a SICHUAN UNIVERSITY   (China)

^b XIHUA UNIVERSITY   (China)

^c Chengdu Antituberculosis Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; ETHAMBUTOL; GUANINE; ISONIAZID; KATG PROTEIN; METHIONINE; PROTEIN EMBB; PROTEIN INHA; REGULATOR PROTEIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ARTICLE; BACTERIUM ISOLATION; CHINA; CODON; CONTROLLED STUDY; DRUG SENSITIVITY; GENE AMPLIFICATION; GENE INSERTION; GENE MUTATION; GEOGRAPHICAL VARIATION (SPECIES); MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; CHINA; CODON; DRUG RESISTANCE, BACTERIAL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; RIFAMPIN;

EID: 48749131687     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Frieden, T.-R., Sterling, T.-R., Munsiff, S.-S., et al. (2003): Tuberculosis. Lancet, 362, 887-899.
2. World Health Organization (2007): Global tuberculosis control: surveillance, planning and financing, 2007. WHO/HTM/TB/2007.376. World Health Organization, Geneva, Switzerland.
3. Dye, C., Scheele, S., Dolin, P., et al. (1999): Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA, 282, 677-686.
4. Campbell, E.-A., Korzheva, N., Mustaev, A., et al. (2001): Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell, 104, 901-912.
5. hot spots". Int. J. Tuberc. Lung Dis., 4, 387-394.
6. Ramaswamy, S. and Musser, J.-M. (1998): Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis., 79, 3-29.
7. Zhang, Y., Heym, B., Allen, B., et al. (1992): The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature, 358, 591-593.
8. Banerjee, A., Dubnau, E., Quemard, A., et al. (1994): inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science, 263, 227-230.
9. Rozwarski, D.-A., Grant, G.-A., Barton, D.-H.-R., et al. (1998): Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science, 279, 98-102.
10. Rinder, H., Mieskes, K.-T., Tortoli, E., et al. (2001): Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: a low-cost, rapid approach. Mol. Cell. Probes, 15, 37-42.
11. Mokrousov, I., Otten, T., Vyshnevskiy, B., et al. (2002): Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing. J. Clin. Microbiol., 40, 3810-3813.
12. Ma, X., Wang, H.-Y., Deng, Y-F., et al. (2006): rpoB gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J. Clin. Microbiol., 44, 3409-3412.
13. Yue, J., Shi, W., Xie, J.-P., et al. (2003): Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol., 41, 2209-2212.
14. Zhang, S.-L., Qi, H., Qiu, D.-L., et al. (2007): Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates recovered from central China. Biochem. Genet., 45, 281-290.
15. Duanmu, H.-J. (2002): Report on fourth national epidemiological sampling survey of tuberculosis. Chin. J. Tuberc. Respir. Dis., 25, 3-7.
16. World Health Organization and International Union against Tuberculosis and Lung Disease (1997): Guidelines for surveillance of drug resistance in tuberculosis. WHO/TB/96.216. World Health Organization, Geneva, Switzerland.
17. Goyal, A., Nagarkar, N.-M., Uppal, K.-S., et al. (1998): Tuberculosis of the pyriform fossa-a rare entity. J. Laryngol. Otol., 112, 782-783.
18. Chan, R.-C.-Y., Hui, M., Chan, E.-W.-C., et al. (2007): Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J. Antimicrob. Chemother., 59, 866-873.
19. Caws, M., Duy, P.-M., Tho, D.-Q., et al. (2006): Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J. Clin. Microbiol., 44, 2333-2337.
20. Hwang, H.-Y., Chang, C.-Y., Chang, L.-L., et al. (2003): Characterization of rifampicin-resistant Mycobacterium tuberculosis in Taiwan. J. Med. Microbiol., 52, 239-245.
21. Jiao, W.-W., Igor, M., Sun, G.-J, et al. (2007): Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin. Med. J., 120, 814-819.
22. Lee, A.-S.-G., Lim, I-H.-K., Tang, L.-L.-H., et al. (2005): High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterum tuberculosis from Singapore. J. Clin. Microbiol., 43, 2026-2027.
23. Mani, C., Selvakumar, N., Narayanan, S., et al. (2001): Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J. Clin. Microbiol., 39, 2987-2990.
24. Hirano, K., Abe, C. and Takahashi, M. (1999): Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J. Clin. Microbiol., 37, 2663-2666.
25. Herrera, L., Jimenez, S., Valverde, A., et al. (2003): Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int. J. Antimicrob. Agents, 21, 403-408.
26. Kim, S.-Y., Park, Y.-J., Kim, W.-I, et al. (2003): Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. Diagn. Microbiol. Infect. Dis., 47, 497-502.
27. Wilson, T.-M., de Lisle, G.-W. and Collins, D.-M. (1995): Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol. Microbiol., 15, 1009-1015.
28. Hazbon, M.-H., del Valle, M.-B., Guerrero, MA., et al. (2005): Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother., 49, 3794-3802.